company background image
XPR logo

Exprivia BIT:XPR Stock Report

Last Price

€1.52

Market Cap

€68.2m

7D

-16.0%

1Y

-3.8%

Updated

18 Jul, 2024

Data

Company Financials

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

My Notes

Capture your thoughts, links and company narrative

Exprivia S.p.A. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Exprivia
Historical stock prices
Current Share Price€1.52
52 Week High€2.08
52 Week Low€1.49
Beta1.08
1 Month Change-11.63%
3 Month Change-10.59%
1 Year Change-3.80%
3 Year Change3.40%
5 Year Change50.50%
Change since IPO-93.77%

Recent News & Updates

Recent updates

Exprivia (BIT:XPR) Is Doing The Right Things To Multiply Its Share Price

Nov 18
Exprivia (BIT:XPR) Is Doing The Right Things To Multiply Its Share Price

Is It Time To Consider Buying Exprivia S.p.A. (BIT:XPR)?

Sep 23
Is It Time To Consider Buying Exprivia S.p.A. (BIT:XPR)?

A Look At The Intrinsic Value Of Exprivia S.p.A. (BIT:XPR)

Aug 30
A Look At The Intrinsic Value Of Exprivia S.p.A. (BIT:XPR)

Exprivia (BIT:XPR) Shareholders Will Want The ROCE Trajectory To Continue

Aug 10
Exprivia (BIT:XPR) Shareholders Will Want The ROCE Trajectory To Continue

What Is Exprivia S.p.A.'s (BIT:XPR) Share Price Doing?

Jun 14
What Is Exprivia S.p.A.'s (BIT:XPR) Share Price Doing?

Exprivia S.p.A.'s (BIT:XPR) Price Is Right But Growth Is Lacking After Shares Rocket 28%

Apr 04
Exprivia S.p.A.'s (BIT:XPR) Price Is Right But Growth Is Lacking After Shares Rocket 28%

Does Exprivia (BIT:XPR) Have A Healthy Balance Sheet?

Mar 01
Does Exprivia (BIT:XPR) Have A Healthy Balance Sheet?

Exprivia (BIT:XPR) Is Looking To Continue Growing Its Returns On Capital

Feb 02
Exprivia (BIT:XPR) Is Looking To Continue Growing Its Returns On Capital

Does Exprivia (BIT:XPR) Have A Healthy Balance Sheet?

Nov 11
Does Exprivia (BIT:XPR) Have A Healthy Balance Sheet?

Exprivia (BIT:XPR) Takes On Some Risk With Its Use Of Debt

Jul 08
Exprivia (BIT:XPR) Takes On Some Risk With Its Use Of Debt

Should You Investigate Exprivia S.p.A. (BIT:XPR) At €1.32?

Jun 10
Should You Investigate Exprivia S.p.A. (BIT:XPR) At €1.32?

Shareholder Returns

XPRIT ITIT Market
7D-16.0%-3.9%2.0%
1Y-3.8%9.4%11.6%

Return vs Industry: XPR underperformed the Italian IT industry which returned 28.6% over the past year.

Return vs Market: XPR underperformed the Italian Market which returned 16.4% over the past year.

Price Volatility

Is XPR's price volatile compared to industry and market?
XPR volatility
XPR Average Weekly Movement7.4%
IT Industry Average Movement4.5%
Market Average Movement4.3%
10% most volatile stocks in IT Market7.6%
10% least volatile stocks in IT Market2.6%

Stable Share Price: XPR's share price has been volatile over the past 3 months.

Volatility Over Time: XPR's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of Italian stocks.

About the Company

FoundedEmployeesCEOWebsite
n/a2,499Domenico Favuzziwww.exprivia.it

Exprivia S.p.A. offers digital transformation solutions in Italy and internationally. It provides big data and analytics, cloud, Internet of things and contextual communication, cyber security, mobile, SAP, business process outsourcing, and network and digital transformation solutions. The company also designs and manages services and infrastructure for call centers, contact centers, and helpdesks.

Exprivia S.p.A. Fundamentals Summary

How do Exprivia's earnings and revenue compare to its market cap?
XPR fundamental statistics
Market cap€68.16m
Earnings (TTM)€13.14m
Revenue (TTM)€197.49m

5.2x

P/E Ratio

0.3x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
XPR income statement (TTM)
Revenue€197.49m
Cost of Revenue€173.65m
Gross Profit€23.84m
Other Expenses€10.70m
Earnings€13.14m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

Aug 06, 2024

Earnings per share (EPS)0.29
Gross Margin12.07%
Net Profit Margin6.65%
Debt/Equity Ratio32.5%

How did XPR perform over the long term?

See historical performance and comparison

Dividends

3.2%

Current Dividend Yield

n/a

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/07/18 07:51
End of Day Share Price 2024/07/16 00:00
Earnings2023/12/31
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Exprivia S.p.A. is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Fabrizio SpagnaAxia Financial Research
Andrea DevitaBanca Akros S.p.A. (ESN)
Laura CarmignaniIntesa Sanpaolo Equity Research